Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Pfizer for InfoPages here.
Pfizer - Latest News [Page 2]
Daily Mouth Rinse Essential to Good Oral Care
Wednesday, 3 May 2006, 3:16 pm | Pfizer
Auckland, 3 May 2006 –Adding New Zealand’s favorite mouthwash *, Listerine Antiseptic Mouthwash, to your daily routine is now clinically proven to provide significantly greater results over brushing alone. More >>
PHARMAC response to UMR survey misleading
Tuesday, 21 February 2006, 5:09 pm | Pfizer
PHARMAC’s response to the UMR survey released today by Pfizer is statistically misleading, and yet again fails to adequately address concerns raised about its performance and access to medicines, Mark Crotty said. More >>
Pfizer Disappointed By Weak Pharmac Response
Wednesday, 31 August 2005, 7:12 pm | Pfizer
Pfizer New Zealand is disappointed, but not surprised, that PHARMAC has failed to address any of the serious issues that have been raised in the Alex Sundakov report on the impact of the country's restrictive medicines policy on the health and well ... More >>
Public strongly supports review of Pharmac
Monday, 29 August 2005, 6:17 pm | Pfizer
Almost seven-in-ten adult New Zealanders strongly support an independent review of the Government’s medicines funding agency Pharmac, according to a survey conducted by UMR Insight last month. More >>
Pharmac Finally Funds World Class Pain Medication
Friday, 24 June 2005, 8:55 am | Pfizer
PFIZER New Zealand has welcomed PHARMAC's decision to widen access to its leading neuropathic pain medication by funding the medicine from 1 July this year, Pfizer General Manager Mark Crotty said today. More >>
Pfizer NZ Response To Medsafe Announcement
Friday, 29 April 2005, 11:28 am | Pfizer
Pfizer New Zealand Ltd welcomes the announcement by Medsafe that it has revised its earlier advice, and will keep the company’s COX-2 inhibitor arthritis medication, Celebrex, on the market, Pfizer New Zealand General Manager Mark Crotty said. More >>
Pfizer New Zealand Response To The IMMP Assertions
Friday, 15 April 2005, 9:28 am | Pfizer
Pfizer New Zealand today strongly disagrees with the statement issued by the IMMP, Pfizer General Manager Mark Crotty said. More >>
Pfizer New Zealand Bextra Advisory
Tuesday, 12 April 2005, 9:35 am | Pfizer
11 April 2005 PFIZER NEW ZEALAND BEXTRA ADVISORY Pfizer New Zealand will voluntarily suspend the marketing and distribution of Bextra and withdraw the product to pharmacy level, following a request from the regulator Medsafe. Pfizer New Zealand general ... More >>
Pfizer voluntarily withdraws Bextra from NZ
Tuesday, 12 April 2005, 9:31 am | Pfizer
Pharmaceutical company Pfizer is voluntarily withdrawing the Cox-2 medicine Bextra from the New Zealand market following a request from Medsafe to suspend distribution and marketing, and will recall supplies of Bextra progressively from wholesale and ... More >>
Pfizer New Zealand Waiting For Medsafe Advice
Friday, 8 April 2005, 5:02 pm | Pfizer
“Medsafe is currently conducting a review of the safety of the class of Cox-2 inhibitors, including Bextra, the results of which are expected next week,” Pfizer NZ General Manger Mark Crotty said today. More >>
Pfizer Disappointed Medsafe May Deny Arthritis Med
Tuesday, 22 February 2005, 10:48 pm | Pfizer
Pfizer New Zealand Ltd is disappointed with a preliminary recommendation by health officials that could deny 60,000 New Zealanders access to important arthritis medications. More >>
Pfizer Response To Pharmac Statement
Friday, 24 December 2004, 10:25 am | Pfizer
Pfizer New Zealand rejects PHARMAC’s statement in its entirety. More >>
Prescribing Information For Depo-Provera
Friday, 19 November 2004, 5:42 pm | Pfizer
Pfizer New Zealand has submitted information to Medsafe regarding the potential for bone mineral density changes in women and adolescents taking DEPO PROVERA, a long acting injectable contraceptive, and is awaiting their decision regarding additional ... More >>
Pfizer to Begin Distribution Animal Vaccines
Tuesday, 12 October 2004, 1:44 pm | Pfizer
Pfizer Animal Health and AgVax Developments Limited (AgVax) are pleased to announce that from 1 December 2004 Pfizer Animal Health will assume responsibilities for the sales and marketing and the distribution of the CSL Animal Health vaccine range. More >>
Pfizer New Zealand Affirms Celebrex Safety
Friday, 1 October 2004, 2:55 pm | Pfizer
In response to patient enquiries about Merck & Co.'s worldwide withdrawal of its COX-2 medicine Vioxx, Pfizer New Zealand has issued an assurance that its anti-arthritis treatment, Celebrex®, is safe. More >>
Health Deadline Presents Challenge for Kiwi Smoker
Thursday, 16 September 2004, 10:04 am | Pfizer
Pfizer Consumer Healthcare, the distributor of Nicorette, the country's leading nicotine replacement therapy(1), is challenging Kiwi smokers to quit during the 12-week countdown to changes to the Smoke Free Environments Act. More >>
Pfizer Boosts Eye Med Program To NZ$820m
Monday, 17 November 2003, 9:47 am | Pfizer
Pfizer Dramatically Boosts Program To $NZ 820 Million To Eliminate Blinding Trachoma In The Developing World More >>
Revolutionary Flea & Roundworm Protection For Cats
Wednesday, 29 October 2003, 10:29 am | Pfizer
A revolutionary new product is now available to protect against Fleas and Roundworms (T. cati). Revolution„· is a world first in parasite control for cats and gives New Zealand cat owners the ability to control both internal and external parasites with ... More >>
Viagra Claim Ignores Evidence
Friday, 29 August 2003, 9:38 am | Pfizer
Pfizer New Zealand is strongly refuting a claim that Viagra, the world’s first and most prescribed oral treatment for erection problems, does more harm than good for relationships. More >>
Pfizer Animal Health Strengthens Local Market
Thursday, 1 May 2003, 10:20 am | Pfizer
Pfizer Animal Health has been significantly strengthened by Pfizer Inc’s global acquisition of Pharmacia Corporation, completed on April 16th 2003. The New Zealand division of Pfizer Animal Health is pleased to announce this development, and looks forward ... More >>
